SIGLEC9 Rabbit pAb
| Target | SIGLEC9 |
|---|---|
| Product Type | Antibody |
| Application | WB |
| Clonality | Polyclonal |
| Isotype | IgG |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 210-340 of human SIGLEC9 (NP_001185487.1). |
| Host Species | Rabbit |
| Species Reactivity | Human, Mouse, Rat |
| Formulation | PBS with 0.01% thimerosal,50% glycerol |
| Research Area | Cancer, Immunology |
| Description/Background | This protein is predicted to enable monosaccharide binding activity and sialic acid binding activity. predicted to be involved in cell adhesion. predicted to act upstream of or within negative regulation of inflammatory response and negative regulation of phagocytosis, engulfment. predicted to be located in external side of plasma membrane. predicted to be active in plasma membrane. |
| Protocols | WB |
| Molecular Weight | 50kDa |
| Purity | Affinity purification |
| Regulatory Statement | For Research Use Only. Not for use in diagnostic procedures. |